Wilson JW. Nocardiosis: updates and clinical overview. Mayo Clin Proc. 2012;87(4):403–7.
PubMed
PubMed Central
Google Scholar
Kurup PV, Randhawa HS, Sandhu RS. A survey of Nocardia asteroides, N. caviae and N. brasiliensis occuring in soil in India. Sabouraudia. 1968;6(3):260–6.
PubMed
CAS
Google Scholar
Han HJ, Kwak MJ, Ha SM, Yang SJ, Kim JD, Cho KH, et al. Genomic characterization of Nocardia seriolae strains isolated from diseased fish. Microbiologyopen. 2019;8(3):e00656.
PubMed
Google Scholar
Conville PS, Brown-Elliott BA, Smith T, Zelazny AM. The complexities of Nocardia taxonomy and identification. J Clin Microbiol. 2018;56(1):e01419–7.
PubMed
CAS
Google Scholar
Weng SS, Zhang HY, Ai JW, Gao Y, Liu YY, Xu B, et al. Rapid detection of Nocardia by next-generation sequencing. Front Cell Infect Microbiol. 2020;10:13.
PubMed
PubMed Central
CAS
Google Scholar
Rodriguez-Nava V, Durupt S, Chyderiotis S, Freydière AM, Karsenty J, de Montclos M, et al. A French multicentric study and review of pulmonary Nocardia spp. in cystic fibrosis patients. Med Microbiol Immunol. 2015;204(4):493–504.
PubMed
CAS
Google Scholar
Haussaire D, Fournier PE, Djiguiba K, Moal V, Legris T, Purgus R, et al. Nocardiosis in the south of France over a 10-years period, 2004-2014. Int J Infect Dis. 2017;57:13–20.
PubMed
Google Scholar
Glupczynski Y, Berhin C, Janssens M, Wauters G. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect. 2006;12(9):905–12.
PubMed
CAS
Google Scholar
Hashemi-Shahraki A, Heidarieh P, Bostanabad SZ, Hashemzadeh M, Feizabadi MM, Schraufnagel D, et al. Genetic diversity and antimicrobial susceptibility of Nocardia species among patients with nocardiosis. Sci Rep. 2015;5:17862.
PubMed
PubMed Central
Google Scholar
Durand T, Vautrin F, Bergeron E, Girard V, Polsinelli S, Monnin V, et al. Assessment of VITEK® MS IVD database V3.0 for identification of Nocardia spp. using two culture media and comparing direct smear and protein extraction procedures. Eur J Clin Microbiol Infect Dis. 2020;39(3):559–67.
PubMed
CAS
Google Scholar
Toyokawa M, Ohana N, Ueda A, Imai M, Tanno D, Honda M, et al. Identification and antimicrobial susceptibility profiles of Nocardia species clinically isolated in Japan. Sci Rep. 2021;11(1):16742.
PubMed
PubMed Central
CAS
Google Scholar
Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19(2):259–82.
PubMed
PubMed Central
CAS
Google Scholar
Carrasco G, Valdezate S, Garrido N, Villalón P, Medina-Pascual MJ, Sáez-Nieto JA. Identification, typing, and phylogenetic relationships of the main clinical Nocardia species in Spain according to their gyrB and rpoB genes. J Clin Microbiol. 2013;51(11):3602–8.
PubMed
PubMed Central
CAS
Google Scholar
Gevers D, Cohan FM, Lawrence JG, Spratt BG, Coenye T, Feil EJ, et al. Opinion: re-evaluating prokaryotic species. Nat Rev Microbiol. 2005;3(9):733–9.
PubMed
CAS
Google Scholar
Shneyer VS. On the species-specificity of DNA: fifty years later. Biochemistry (Mosc). 2007;72(12):1377–84.
CAS
Google Scholar
McTaggart LR, Richardson SE, Witkowska M, Zhang SX. Phylogeny and identification of Nocardia species on the basis of multilocus sequence analysis. J Clin Microbiol. 2010;48(12):4525–33.
PubMed
PubMed Central
CAS
Google Scholar
Wei M, Wang P, Yang C, Gu L. Molecular identification and phylogenetic relationships of clinical Nocardia isolates. Antonie Van Leeuwenhoek. 2019;112(12):1755–66.
PubMed
CAS
Google Scholar
Clinical and Laboratory Standards Institute (CLSI). Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard-second edition CLSI document M24-A2. Wayne: CLSI; 2011.
Google Scholar
Wei M, Wang P, Qu J, Li R, Liu Y, Gu L, et al. Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China. J Glob Antimicrob Resist. 2017;11:183–7.
PubMed
Google Scholar
Lu SH, Qian ZW, Mou PP, Xie L. Clinical Nocardia species: identification, clinical characteristics, and antimicrobial susceptibility in Shandong, China. Bosn J Basic Med Sci. 2020;20(4):531–8.
PubMed
PubMed Central
CAS
Google Scholar
Yi M, Wang L, Xu W, Sheng L, Jiang L, Yang F, et al. Species distribution and antibiotic susceptibility of Nocardia isolates from Yantai, China. Infect Drug Resist. 2019;12:3653–61.
PubMed
PubMed Central
CAS
Google Scholar
Gascuel O. BIONJ: an improved version of the NJ algorithm based on a simple model of sequence data. Mol Biol Evol. 1997;14(7):685–95.
PubMed
CAS
Google Scholar
Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980;16(2):111–20.
PubMed
CAS
Google Scholar
Tan YE, Chen SC, Halliday CL. Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: results from a large tertiary laboratory in Australia. J Glob Antimicrob Resist. 2020;20:110–7.
PubMed
Google Scholar
Schlaberg R, Fisher MA, Hanson KE. Susceptibility profiles of Nocardia isolates based on current taxonomy. Antimicrob Agents Chemother. 2014;58(2):795–800.
PubMed
PubMed Central
Google Scholar
Wallace RJ Jr, Steele LC, Sumter G, Smith JM. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother. 1988;32(12):1776–9.
PubMed
PubMed Central
CAS
Google Scholar
Carrasco G, de Dios CJ, Garrido N, Valdezate S, Cantón R, Sáez-Nieto JA. Shortcomings of the commercial MALDI-TOF MS database and use of MLSA as an arbiter in the identification of Nocardia species. Front Microbiol. 2016;7:542.
PubMed
PubMed Central
Google Scholar
Valdezate S, Garrido N, Carrasco G, Medina-Pascual MJ, Villalón P, Navarro AM, et al. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain. J Antimicrob Chemother. 2017;72(3):754–61.
PubMed
CAS
Google Scholar
Schlaberg R, Huard RC, Della-Latta P. Nocardia cyriacigeorgica, an emerging pathogen in the United States. J Clin Microbiol. 2008;46(1):265–73.
PubMed
CAS
Google Scholar
Lebeaux D, Bergeron E, Berthet J, Djadi-Prat J, Mouniée D, Boiron P, et al. Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory, 2010-2015. Clin Microbiol Infect. 2019;25(4):489–95.
PubMed
CAS
Google Scholar
Hamdi AM, Fida M, Deml SM, Abu Saleh OM, Wengenack NL. Retrospective analysis of antimicrobial susceptibility profiles of Nocardia species from a tertiary hospital and reference laboratory, 2011 to 2017. Antimicrob Agents Chemother. 2020;64(3):e01868–19.
PubMed
PubMed Central
CAS
Google Scholar
Huang L, Chen X, Xu H, Sun L, Li C, Guo W, et al. Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017. Diagn Microbiol Infect Dis. 2019;94(2):165–72.
PubMed
CAS
Google Scholar
Martínez-Barricarte R. Isolated Nocardiosis, an unrecognized primary immunodeficiency? Front Immunol. 2020;11:590239.
PubMed
PubMed Central
Google Scholar
Hernandez-Hernandez F, Lopez-Martinez R, Mendez-Tovar LJ, Manzano-Gayosso P. Nocardia brasiliensis: in vitro and in vivo growth response to steroid sex hormones. Mycopathologia. 1995;132(2):79–85.
PubMed
CAS
Google Scholar
Uhde KB, Pathak S, McCullum I Jr, Jannat-Khah DP, Shadomy SV, Dykewicz CA, et al. Antimicrobial-resistant Nocardia isolates, United States, 1995-2004. Clin Infect Dis. 2010;51(12):1445–8.
PubMed
Google Scholar
Brown-Elliott BA, Biehle J, Conville PS, Cohen S, Saubolle M, Sussland D, et al. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey. J Clin Microbiol. 2012;50(3):670–2.
PubMed
PubMed Central
CAS
Google Scholar
Cercenado E, Marín M, Sánchez-Martínez M, Cuevas O, Martínez-Alarcón J, Bouza E. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother. 2007;51(3):1102–4.
PubMed
CAS
Google Scholar
Lowman W, Aithma N. Antimicrobial susceptibility testing and profiling of Nocardia species and other aerobic actinomycetes from South Africa: comparative evaluation of broth microdilution versus the Etest. J Clin Microbiol. 2010;48(12):4534–40.
PubMed
PubMed Central
Google Scholar
McTaggart LR, Doucet J, Witkowska M, Richardson SE. Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis. Antimicrob Agents Chemother. 2015;59(1):269–75.
PubMed
Google Scholar
Larruskain J, Idigoras P, Marimón JM, Pérez-Trallero E. Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents. Antimicrob Agents Chemother. 2011;55(6):2995–8.
PubMed
PubMed Central
CAS
Google Scholar
Minero MV, Marín M, Cercenado E, Rabadán PM, Bouza E, Muñoz P. Nocardiosis at the turn of the century. Medicine (Baltimore). 2009;88(4):250–61.
Google Scholar
Tremblay J, Thibert L, Alarie I, Valiquette L, Pépin J. Nocardiosis in Quebec, Canada, 1988-2008. Clin Microbiol Infect. 2011;17(5):690–6.
PubMed
CAS
Google Scholar
Gombert ME, Aulicino TM. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Antimicrob Agents Chemother. 1983;24(5):810–1.
PubMed
PubMed Central
CAS
Google Scholar
Andriole VT. The quinolones: past, present, and future. Clin Infect Dis. 2005;41 Suppl 2:S113–9.
PubMed
Google Scholar
Conville PS, Brown-Elliott BA, Wallace RJ Jr, Witebsky FG, Koziol D, Hall GS, et al. Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species. J Clin Microbiol. 2012;50(4):1270–80.
PubMed
PubMed Central
CAS
Google Scholar
McNeil MM, Brown JM. The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev. 1994;7(3):357–417.
PubMed
PubMed Central
CAS
Google Scholar
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30(12):2725–9.
PubMed
PubMed Central
CAS
Google Scholar